| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5582040 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 8 Pages |
Abstract
The diagnostic workup for PTCL in the United States varies widely and often lacks important phenotypic information to fully characterize the lymphoma. Gaps in testing of selected markers should be filled, given the impending revision to the World Health Organization classification. The accuracy of diagnosis will become increasingly important as we enter the era of targeted treatment for PTCL.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Eric D. Hsi, Steven M. Horwitz, Kenneth R. Carson, Lauren C. Pinter-Brown, Steven T. Rosen, Barbara Pro, Massimo Federico, Christian Gisselbrecht, Marc Schwartz, Lisa A. Bellm, Mark Acosta, Angela M. Collie, Aaron M. Gruver, Bartosz J. Grzywacz,